woman

1 stories · following the connections

Business

Agile Therapeutics Reports Third Quarter 2016 Financial Results and Announces Completion of Subject Visits for Twirla® Phase 3 SECURE Clinical Trial

By Nasdaq OMXNov 7, 2016, 9:10 PM UTC